 | • レポートコード：MRC2-11QY04309 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はポイントオブケア感染性疾患のグローバル市場について調査・分析したレポートです。種類別（HIV POC、クロストリジウム・ディフィシルPOC、HBV POC、肺炎/連鎖球菌関連感染症、呼吸器合胞体ウイルス（RSV）POC、HPV POC、インフルエンザ/インフルエンザPOC、HCV POC、MRSA POC、TBおよび薬剤耐性結核POC）市場規模、用途別（病院、診療所、在宅、生活支援医療施設、研究所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ポイントオブケア感染性疾患の競争状況、市場シェア ・世界のポイントオブケア感染性疾患市場：種類別市場規模 2015年-2020年（HIV POC、クロストリジウム・ディフィシルPOC、HBV POC、肺炎/連鎖球菌関連感染症、呼吸器合胞体ウイルス（RSV）POC、HPV POC、インフルエンザ/インフルエンザPOC、HCV POC、MRSA POC、TBおよび薬剤耐性結核POC） ・世界のポイントオブケア感染性疾患市場：種類別市場規模予測 2021年-2026年（HIV POC、クロストリジウム・ディフィシルPOC、HBV POC、肺炎/連鎖球菌関連感染症、呼吸器合胞体ウイルス（RSV）POC、HPV POC、インフルエンザ/インフルエンザPOC、HCV POC、MRSA POC、TBおよび薬剤耐性結核POC） ・世界のポイントオブケア感染性疾患市場：用途別市場規模 2015年-2020年（病院、診療所、在宅、生活支援医療施設、研究所、その他） ・世界のポイントオブケア感染性疾患市場：用途別市場規模予測 2021年-2026年（病院、診療所、在宅、生活支援医療施設、研究所、その他） ・北米のポイントオブケア感染性疾患市場分析：米国、カナダ ・ヨーロッパのポイントオブケア感染性疾患市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのポイントオブケア感染性疾患市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のポイントオブケア感染性疾患市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのポイントオブケア感染性疾患市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Siemens Healthineers、Trivitron Healthcare、F. Hoffmann-La Roche Ltd、Abbott、Quest Diagnostics, Inc、BD & Company、Chembio Diagnostics Inc、Trinity Biotech、Cardinal Health、Bio-Rad Labs Inc.、bioMérieux SA、Thermo Fisher Scientific Inc、Sight Diagnostics Ltd.、Gene POC、Ortho-Clinical Diagnostics、OJ-Bio Ltd. ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
A point-of-care (POC) test is performed at or near the site where a patient initially encounters the health care system, has a rapid turnaround time (approximately 15 min), and provides actionable information that can lead to a change in patient management.
Market Analysis and Insights: Global Point of Care Infectious Disease Market
The global Point of Care Infectious Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Point of Care Infectious Disease Scope and Market Size
Point of Care Infectious Disease market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Point of Care Infectious Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Siemens Healthineers
Trivitron Healthcare
F. Hoffmann-La Roche Ltd
Abbott
Quest Diagnostics, Inc
BD & Company
Chembio Diagnostics Inc
Trinity Biotech
Cardinal Health
Bio-Rad Labs Inc.
bioMérieux SA
Thermo Fisher Scientific Inc
Sight Diagnostics Ltd.
Gene POC
Ortho-Clinical Diagnostics
OJ-Bio Ltd.
Market segment by Type, the product can be split into
HIV POC
Clostridium difficile POC
HBV POC
Pneumonia or Streptococcus associated infections
Respiratory syncytial virus (RSV) POC
HPV POC
Influenza/Flu POC
HCV POC
MRSA POC
TB and drug-resistant TB POC
Market segment by Application, split into
Hospitals
Clinics
Home
Assisted Living Healthcare Facilities
Laboratories
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Point of Care Infectious Disease Revenue
1.4 Market by Type
1.4.1 Global Point of Care Infectious Disease Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 HIV POC
1.4.3 Clostridium difficile POC
1.4.4 HBV POC
1.4.5 Pneumonia or Streptococcus associated infections
1.4.6 Respiratory syncytial virus (RSV) POC
1.4.7 HPV POC
1.4.8 Influenza/Flu POC
1.4.9 HCV POC
1.4.10 MRSA POC
1.4.11 TB and drug-resistant TB POC
1.5 Market by Application
1.5.1 Global Point of Care Infectious Disease Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Home
1.5.5 Assisted Living Healthcare Facilities
1.5.6 Laboratories
1.5.7 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Point of Care Infectious Disease Market Perspective (2015-2026)
2.2 Global Point of Care Infectious Disease Growth Trends by Regions
2.2.1 Point of Care Infectious Disease Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Point of Care Infectious Disease Historic Market Share by Regions (2015-2020)
2.2.3 Point of Care Infectious Disease Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Point of Care Infectious Disease Market Growth Strategy
2.3.6 Primary Interviews with Key Point of Care Infectious Disease Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Point of Care Infectious Disease Players by Market Size
3.1.1 Global Top Point of Care Infectious Disease Players by Revenue (2015-2020)
3.1.2 Global Point of Care Infectious Disease Revenue Market Share by Players (2015-2020)
3.1.3 Global Point of Care Infectious Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Point of Care Infectious Disease Market Concentration Ratio
3.2.1 Global Point of Care Infectious Disease Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Point of Care Infectious Disease Revenue in 2019
3.3 Point of Care Infectious Disease Key Players Head office and Area Served
3.4 Key Players Point of Care Infectious Disease Product Solution and Service
3.5 Date of Enter into Point of Care Infectious Disease Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Point of Care Infectious Disease Historic Market Size by Type (2015-2020)
4.2 Global Point of Care Infectious Disease Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Point of Care Infectious Disease Market Size by Application (2015-2020)
5.2 Global Point of Care Infectious Disease Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Point of Care Infectious Disease Market Size (2015-2020)
6.2 Point of Care Infectious Disease Key Players in North America (2019-2020)
6.3 North America Point of Care Infectious Disease Market Size by Type (2015-2020)
6.4 North America Point of Care Infectious Disease Market Size by Application (2015-2020)
7 Europe
7.1 Europe Point of Care Infectious Disease Market Size (2015-2020)
7.2 Point of Care Infectious Disease Key Players in Europe (2019-2020)
7.3 Europe Point of Care Infectious Disease Market Size by Type (2015-2020)
7.4 Europe Point of Care Infectious Disease Market Size by Application (2015-2020)
8 China
8.1 China Point of Care Infectious Disease Market Size (2015-2020)
8.2 Point of Care Infectious Disease Key Players in China (2019-2020)
8.3 China Point of Care Infectious Disease Market Size by Type (2015-2020)
8.4 China Point of Care Infectious Disease Market Size by Application (2015-2020)
9 Japan
9.1 Japan Point of Care Infectious Disease Market Size (2015-2020)
9.2 Point of Care Infectious Disease Key Players in Japan (2019-2020)
9.3 Japan Point of Care Infectious Disease Market Size by Type (2015-2020)
9.4 Japan Point of Care Infectious Disease Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Point of Care Infectious Disease Market Size (2015-2020)
10.2 Point of Care Infectious Disease Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Point of Care Infectious Disease Market Size by Type (2015-2020)
10.4 Southeast Asia Point of Care Infectious Disease Market Size by Application (2015-2020)
11 India
11.1 India Point of Care Infectious Disease Market Size (2015-2020)
11.2 Point of Care Infectious Disease Key Players in India (2019-2020)
11.3 India Point of Care Infectious Disease Market Size by Type (2015-2020)
11.4 India Point of Care Infectious Disease Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Point of Care Infectious Disease Market Size (2015-2020)
12.2 Point of Care Infectious Disease Key Players in Central & South America (2019-2020)
12.3 Central & South America Point of Care Infectious Disease Market Size by Type (2015-2020)
12.4 Central & South America Point of Care Infectious Disease Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Siemens Healthineers
13.1.1 Siemens Healthineers Company Details
13.1.2 Siemens Healthineers Business Overview
13.1.3 Siemens Healthineers Point of Care Infectious Disease Introduction
13.1.4 Siemens Healthineers Revenue in Point of Care Infectious Disease Business (2015-2020))
13.1.5 Siemens Healthineers Recent Development
13.2 Trivitron Healthcare
13.2.1 Trivitron Healthcare Company Details
13.2.2 Trivitron Healthcare Business Overview
13.2.3 Trivitron Healthcare Point of Care Infectious Disease Introduction
13.2.4 Trivitron Healthcare Revenue in Point of Care Infectious Disease Business (2015-2020)
13.2.5 Trivitron Healthcare Recent Development
13.3 F. Hoffmann-La Roche Ltd
13.3.1 F. Hoffmann-La Roche Ltd Company Details
13.3.2 F. Hoffmann-La Roche Ltd Business Overview
13.3.3 F. Hoffmann-La Roche Ltd Point of Care Infectious Disease Introduction
13.3.4 F. Hoffmann-La Roche Ltd Revenue in Point of Care Infectious Disease Business (2015-2020)
13.3.5 F. Hoffmann-La Roche Ltd Recent Development
13.4 Abbott
13.4.1 Abbott Company Details
13.4.2 Abbott Business Overview
13.4.3 Abbott Point of Care Infectious Disease Introduction
13.4.4 Abbott Revenue in Point of Care Infectious Disease Business (2015-2020)
13.4.5 Abbott Recent Development
13.5 Quest Diagnostics, Inc
13.5.1 Quest Diagnostics, Inc Company Details
13.5.2 Quest Diagnostics, Inc Business Overview
13.5.3 Quest Diagnostics, Inc Point of Care Infectious Disease Introduction
13.5.4 Quest Diagnostics, Inc Revenue in Point of Care Infectious Disease Business (2015-2020)
13.5.5 Quest Diagnostics, Inc Recent Development
13.6 BD & Company
13.6.1 BD & Company Company Details
13.6.2 BD & Company Business Overview
13.6.3 BD & Company Point of Care Infectious Disease Introduction
13.6.4 BD & Company Revenue in Point of Care Infectious Disease Business (2015-2020)
13.6.5 BD & Company Recent Development
13.7 Chembio Diagnostics Inc
13.7.1 Chembio Diagnostics Inc Company Details
13.7.2 Chembio Diagnostics Inc Business Overview
13.7.3 Chembio Diagnostics Inc Point of Care Infectious Disease Introduction
13.7.4 Chembio Diagnostics Inc Revenue in Point of Care Infectious Disease Business (2015-2020)
13.7.5 Chembio Diagnostics Inc Recent Development
13.8 Trinity Biotech
13.8.1 Trinity Biotech Company Details
13.8.2 Trinity Biotech Business Overview
13.8.3 Trinity Biotech Point of Care Infectious Disease Introduction
13.8.4 Trinity Biotech Revenue in Point of Care Infectious Disease Business (2015-2020)
13.8.5 Trinity Biotech Recent Development
13.9 Cardinal Health
13.9.1 Cardinal Health Company Details
13.9.2 Cardinal Health Business Overview
13.9.3 Cardinal Health Point of Care Infectious Disease Introduction
13.9.4 Cardinal Health Revenue in Point of Care Infectious Disease Business (2015-2020)
13.9.5 Cardinal Health Recent Development
13.10 Bio-Rad Labs Inc.
13.10.1 Bio-Rad Labs Inc. Company Details
13.10.2 Bio-Rad Labs Inc. Business Overview
13.10.3 Bio-Rad Labs Inc. Point of Care Infectious Disease Introduction
13.10.4 Bio-Rad Labs Inc. Revenue in Point of Care Infectious Disease Business (2015-2020)
13.10.5 Bio-Rad Labs Inc. Recent Development
13.11 bioMérieux SA
10.11.1 bioMérieux SA Company Details
10.11.2 bioMérieux SA Business Overview
10.11.3 bioMérieux SA Point of Care Infectious Disease Introduction
10.11.4 bioMérieux SA Revenue in Point of Care Infectious Disease Business (2015-2020)
10.11.5 bioMérieux SA Recent Development
13.12 Thermo Fisher Scientific Inc
10.12.1 Thermo Fisher Scientific Inc Company Details
10.12.2 Thermo Fisher Scientific Inc Business Overview
10.12.3 Thermo Fisher Scientific Inc Point of Care Infectious Disease Introduction
10.12.4 Thermo Fisher Scientific Inc Revenue in Point of Care Infectious Disease Business (2015-2020)
10.12.5 Thermo Fisher Scientific Inc Recent Development
13.13 Sight Diagnostics Ltd.
10.13.1 Sight Diagnostics Ltd. Company Details
10.13.2 Sight Diagnostics Ltd. Business Overview
10.13.3 Sight Diagnostics Ltd. Point of Care Infectious Disease Introduction
10.13.4 Sight Diagnostics Ltd. Revenue in Point of Care Infectious Disease Business (2015-2020)
10.13.5 Sight Diagnostics Ltd. Recent Development
13.14 Gene POC
10.14.1 Gene POC Company Details
10.14.2 Gene POC Business Overview
10.14.3 Gene POC Point of Care Infectious Disease Introduction
10.14.4 Gene POC Revenue in Point of Care Infectious Disease Business (2015-2020)
10.14.5 Gene POC Recent Development
13.15 Ortho-Clinical Diagnostics
10.15.1 Ortho-Clinical Diagnostics Company Details
10.15.2 Ortho-Clinical Diagnostics Business Overview
10.15.3 Ortho-Clinical Diagnostics Point of Care Infectious Disease Introduction
10.15.4 Ortho-Clinical Diagnostics Revenue in Point of Care Infectious Disease Business (2015-2020)
10.15.5 Ortho-Clinical Diagnostics Recent Development
13.16 OJ-Bio Ltd.
10.16.1 OJ-Bio Ltd. Company Details
10.16.2 OJ-Bio Ltd. Business Overview
10.16.3 OJ-Bio Ltd. Point of Care Infectious Disease Introduction
10.16.4 OJ-Bio Ltd. Revenue in Point of Care Infectious Disease Business (2015-2020)
10.16.5 OJ-Bio Ltd. Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Point of Care Infectious Disease Key Market Segments
Table 2. Key Players Covered: Ranking by Point of Care Infectious Disease Revenue
Table 3. Ranking of Global Top Point of Care Infectious Disease Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Point of Care Infectious Disease Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of HIV POC
Table 6. Key Players of Clostridium difficile POC
Table 7. Key Players of HBV POC
Table 8. Key Players of Pneumonia or Streptococcus associated infections
Table 9. Key Players of Respiratory syncytial virus (RSV) POC
Table 10. Key Players of HPV POC
Table 11. Key Players of Influenza/Flu POC
Table 12. Key Players of HCV POC
Table 13. Key Players of MRSA POC
Table 14. Key Players of TB and drug-resistant TB POC
Table 15. Global Point of Care Infectious Disease Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 16. Global Point of Care Infectious Disease Market Size by Regions (US$ Million): 2020 VS 2026
Table 17. Global Point of Care Infectious Disease Market Size by Regions (2015-2020) (US$ Million)
Table 18. Global Point of Care Infectious Disease Market Share by Regions (2015-2020)
Table 19. Global Point of Care Infectious Disease Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 20. Global Point of Care Infectious Disease Market Share by Regions (2021-2026)
Table 21. Market Top Trends
Table 22. Key Drivers: Impact Analysis
Table 23. Key Challenges
Table 24. Point of Care Infectious Disease Market Growth Strategy
Table 25. Main Points Interviewed from Key Point of Care Infectious Disease Players
Table 26. Global Point of Care Infectious Disease Revenue by Players (2015-2020) (Million US$)
Table 27. Global Point of Care Infectious Disease Market Share by Players (2015-2020)
Table 28. Global Top Point of Care Infectious Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Point of Care Infectious Disease as of 2019)
Table 29. Global Point of Care Infectious Disease by Players Market Concentration Ratio (CR5 and HHI)
Table 30. Key Players Headquarters and Area Served
Table 31. Key Players Point of Care Infectious Disease Product Solution and Service
Table 32. Date of Enter into Point of Care Infectious Disease Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Point of Care Infectious Disease Market Size by Type (2015-2020) (Million US$)
Table 35. Global Point of Care Infectious Disease Market Size Share by Type (2015-2020)
Table 36. Global Point of Care Infectious Disease Revenue Market Share by Type (2021-2026)
Table 37. Global Point of Care Infectious Disease Market Size Share by Application (2015-2020)
Table 38. Global Point of Care Infectious Disease Market Size by Application (2015-2020) (Million US$)
Table 39. Global Point of Care Infectious Disease Market Size Share by Application (2021-2026)
Table 40. North America Key Players Point of Care Infectious Disease Revenue (2019-2020) (Million US$)
Table 41. North America Key Players Point of Care Infectious Disease Market Share (2019-2020)
Table 42. North America Point of Care Infectious Disease Market Size by Type (2015-2020) (Million US$)
Table 43. North America Point of Care Infectious Disease Market Share by Type (2015-2020)
Table 44. North America Point of Care Infectious Disease Market Size by Application (2015-2020) (Million US$)
Table 45. North America Point of Care Infectious Disease Market Share by Application (2015-2020)
Table 46. Europe Key Players Point of Care Infectious Disease Revenue (2019-2020) (Million US$)
Table 47. Europe Key Players Point of Care Infectious Disease Market Share (2019-2020)
Table 48. Europe Point of Care Infectious Disease Market Size by Type (2015-2020) (Million US$)
Table 49. Europe Point of Care Infectious Disease Market Share by Type (2015-2020)
Table 50. Europe Point of Care Infectious Disease Market Size by Application (2015-2020) (Million US$)
Table 51. Europe Point of Care Infectious Disease Market Share by Application (2015-2020)
Table 52. China Key Players Point of Care Infectious Disease Revenue (2019-2020) (Million US$)
Table 53. China Key Players Point of Care Infectious Disease Market Share (2019-2020)
Table 54. China Point of Care Infectious Disease Market Size by Type (2015-2020) (Million US$)
Table 55. China Point of Care Infectious Disease Market Share by Type (2015-2020)
Table 56. China Point of Care Infectious Disease Market Size by Application (2015-2020) (Million US$)
Table 57. China Point of Care Infectious Disease Market Share by Application (2015-2020)
Table 58. Japan Key Players Point of Care Infectious Disease Revenue (2019-2020) (Million US$)
Table 59. Japan Key Players Point of Care Infectious Disease Market Share (2019-2020)
Table 60. Japan Point of Care Infectious Disease Market Size by Type (2015-2020) (Million US$)
Table 61. Japan Point of Care Infectious Disease Market Share by Type (2015-2020)
Table 62. Japan Point of Care Infectious Disease Market Size by Application (2015-2020) (Million US$)
Table 63. Japan Point of Care Infectious Disease Market Share by Application (2015-2020)
Table 64. Southeast Asia Key Players Point of Care Infectious Disease Revenue (2019-2020) (Million US$)
Table 65. Southeast Asia Key Players Point of Care Infectious Disease Market Share (2019-2020)
Table 66. Southeast Asia Point of Care Infectious Disease Market Size by Type (2015-2020) (Million US$)
Table 67. Southeast Asia Point of Care Infectious Disease Market Share by Type (2015-2020)
Table 68. Southeast Asia Point of Care Infectious Disease Market Size by Application (2015-2020) (Million US$)
Table 69. Southeast Asia Point of Care Infectious Disease Market Share by Application (2015-2020)
Table 70. India Key Players Point of Care Infectious Disease Revenue (2019-2020) (Million US$)
Table 71. India Key Players Point of Care Infectious Disease Market Share (2019-2020)
Table 72. India Point of Care Infectious Disease Market Size by Type (2015-2020) (Million US$)
Table 73. India Point of Care Infectious Disease Market Share by Type (2015-2020)
Table 74. India Point of Care Infectious Disease Market Size by Application (2015-2020) (Million US$)
Table 75. India Point of Care Infectious Disease Market Share by Application (2015-2020)
Table 76. Central & South America Key Players Point of Care Infectious Disease Revenue (2019-2020) (Million US$)
Table 77. Central & South America Key Players Point of Care Infectious Disease Market Share (2019-2020)
Table 78. Central & South America Point of Care Infectious Disease Market Size by Type (2015-2020) (Million US$)
Table 79. Central & South America Point of Care Infectious Disease Market Share by Type (2015-2020)
Table 80. Central & South America Point of Care Infectious Disease Market Size by Application (2015-2020) (Million US$)
Table 81. Central & South America Point of Care Infectious Disease Market Share by Application (2015-2020)
Table 82. Siemens Healthineers Company Details
Table 83. Siemens Healthineers Business Overview
Table 84. Siemens Healthineers Product
Table 85. Siemens Healthineers Revenue in Point of Care Infectious Disease Business (2015-2020) (Million US$)
Table 86. Siemens Healthineers Recent Development
Table 87. Trivitron Healthcare Company Details
Table 88. Trivitron Healthcare Business Overview
Table 89. Trivitron Healthcare Product
Table 90. Trivitron Healthcare Revenue in Point of Care Infectious Disease Business (2015-2020) (Million US$)
Table 91. Trivitron Healthcare Recent Development
Table 92. F. Hoffmann-La Roche Ltd Company Details
Table 93. F. Hoffmann-La Roche Ltd Business Overview
Table 94. F. Hoffmann-La Roche Ltd Product
Table 95. F. Hoffmann-La Roche Ltd Revenue in Point of Care Infectious Disease Business (2015-2020) (Million US$)
Table 96. F. Hoffmann-La Roche Ltd Recent Development
Table 97. Abbott Company Details
Table 98. Abbott Business Overview
Table 99. Abbott Product
Table 100. Abbott Revenue in Point of Care Infectious Disease Business (2015-2020) (Million US$)
Table 101. Abbott Recent Development
Table 102. Quest Diagnostics, Inc Company Details
Table 103. Quest Diagnostics, Inc Business Overview
Table 104. Quest Diagnostics, Inc Product
Table 105. Quest Diagnostics, Inc Revenue in Point of Care Infectious Disease Business (2015-2020) (Million US$)
Table 106. Quest Diagnostics, Inc Recent Development
Table 107. BD & Company Company Details
Table 108. BD & Company Business Overview
Table 109. BD & Company Product
Table 110. BD & Company Revenue in Point of Care Infectious Disease Business (2015-2020) (Million US$)
Table 111. BD & Company Recent Development
Table 112. Chembio Diagnostics Inc Company Details
Table 113. Chembio Diagnostics Inc Business Overview
Table 114. Chembio Diagnostics Inc Product
Table 115. Chembio Diagnostics Inc Revenue in Point of Care Infectious Disease Business (2015-2020) (Million US$)
Table 116. Chembio Diagnostics Inc Recent Development
Table 117. Trinity Biotech Business Overview
Table 118. Trinity Biotech Product
Table 119. Trinity Biotech Company Details
Table 120. Trinity Biotech Revenue in Point of Care Infectious Disease Business (2015-2020) (Million US$)
Table 121. Trinity Biotech Recent Development
Table 122. Cardinal Health Company Details
Table 123. Cardinal Health Business Overview
Table 124. Cardinal Health Product
Table 125. Cardinal Health Revenue in Point of Care Infectious Disease Business (2015-2020) (Million US$)
Table 126. Cardinal Health Recent Development
Table 127. Bio-Rad Labs Inc. Company Details
Table 128. Bio-Rad Labs Inc. Business Overview
Table 129. Bio-Rad Labs Inc. Product
Table 130. Bio-Rad Labs Inc. Revenue in Point of Care Infectious Disease Business (2015-2020) (Million US$)
Table 131. Bio-Rad Labs Inc. Recent Development
Table 132. bioMérieux SA Company Details
Table 133. bioMérieux SA Business Overview
Table 134. bioMérieux SA Product
Table 135. bioMérieux SA Revenue in Point of Care Infectious Disease Business (2015-2020) (Million US$)
Table 136. bioMérieux SA Recent Development
Table 137. Thermo Fisher Scientific Inc Company Details
Table 138. Thermo Fisher Scientific Inc Business Overview
Table 139. Thermo Fisher Scientific Inc Product
Table 140. Thermo Fisher Scientific Inc Revenue in Point of Care Infectious Disease Business (2015-2020) (Million US$)
Table 141. Thermo Fisher Scientific Inc Recent Development
Table 142. Sight Diagnostics Ltd. Company Details
Table 143. Sight Diagnostics Ltd. Business Overview
Table 144. Sight Diagnostics Ltd. Product
Table 145. Sight Diagnostics Ltd. Revenue in Point of Care Infectious Disease Business (2015-2020) (Million US$)
Table 146. Sight Diagnostics Ltd. Recent Development
Table 147. Gene POC Company Details
Table 148. Gene POC Business Overview
Table 149. Gene POC Product
Table 150. Gene POC Revenue in Point of Care Infectious Disease Business (2015-2020) (Million US$)
Table 151. Gene POC Recent Development
Table 152. Ortho-Clinical Diagnostics Company Details
Table 153. Ortho-Clinical Diagnostics Business Overview
Table 154. Ortho-Clinical Diagnostics Product
Table 155. Ortho-Clinical Diagnostics Revenue in Point of Care Infectious Disease Business (2015-2020) (Million US$)
Table 156. Ortho-Clinical Diagnostics Recent Development
Table 157. OJ-Bio Ltd. Company Details
Table 158. OJ-Bio Ltd. Business Overview
Table 159. OJ-Bio Ltd. Product
Table 160. OJ-Bio Ltd. Revenue in Point of Care Infectious Disease Business (2015-2020) (Million US$)
Table 161. OJ-Bio Ltd. Recent Development
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Point of Care Infectious Disease Market Share by Type: 2020 VS 2026
Figure 2. HIV POC Features
Figure 3. Clostridium difficile POC Features
Figure 4. HBV POC Features
Figure 5. Pneumonia or Streptococcus associated infections Features
Figure 6. Respiratory syncytial virus (RSV) POC Features
Figure 7. HPV POC Features
Figure 8. Influenza/Flu POC Features
Figure 9. HCV POC Features
Figure 10. MRSA POC Features
Figure 11. TB and drug-resistant TB POC Features
Figure 12. Global Point of Care Infectious Disease Market Share by Application: 2020 VS 2026
Figure 13. Hospitals Case Studies
Figure 14. Clinics Case Studies
Figure 15. Home Case Studies
Figure 16. Assisted Living Healthcare Facilities Case Studies
Figure 17. Laboratories Case Studies
Figure 18. Others Case Studies
Figure 19. Point of Care Infectious Disease Report Years Considered
Figure 20. Global Point of Care Infectious Disease Market Size YoY Growth 2015-2026 (US$ Million)
Figure 21. Global Point of Care Infectious Disease Market Share by Regions: 2020 VS 2026
Figure 22. Global Point of Care Infectious Disease Market Share by Regions (2021-2026)
Figure 23. Porter's Five Forces Analysis
Figure 24. Global Point of Care Infectious Disease Market Share by Players in 2019
Figure 25. Global Top Point of Care Infectious Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Point of Care Infectious Disease as of 2019
Figure 26. The Top 10 and 5 Players Market Share by Point of Care Infectious Disease Revenue in 2019
Figure 27. North America Point of Care Infectious Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Europe Point of Care Infectious Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. China Point of Care Infectious Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. Japan Point of Care Infectious Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 31. Southeast Asia Point of Care Infectious Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 32. India Point of Care Infectious Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 33. Central & South America Point of Care Infectious Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 34. Bottom-up and Top-down Approaches for This Report
Figure 35. Data Triangulation
Figure 36. Key Executives Interviewed
ポイントオブケア感染症診断の世界市場（～2026年） Point of care diagnosis allows for early detection of diseases and can greatly impact the medical outcome of the disease treatment. The point-of-care infectious disease diagnostics market is expected to register a fast growth over the forecast period owing to the emerging trend of patient-centric se…- 感染症治療薬の世界市場（～2026年） Infectious disease therapeutics are targeting on main infectious diseases by using drugs and vaccines to prevent, control and cure them. Major driving factors of the global infectious disease therapeutics market are favorable reimbursement policies for infectious diseases, increasing incidence of in…
- 感染症治療の世界市場（～2026年） Treatment for Infectious Diseases. Treatment of viral infections such as HIV involves patient care and moral support including antiretroviral therapy. Bacterial infections can be treated by administering antibiotics to the patients. Market Analysis and Insights: Global Infectious Disease Treatment M…
- 獣医感染症治療薬の世界市場（～2026年） Market Analysis and Insights: Global Veterinary Infectious Disease Therapeutics Market The global Veterinary Infectious Disease Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Veterinary Infectious Disease…
- 感染症診断検査の世界市場（～2026年） Market Analysis and Insights: Global Infectious Disease Diagnostic Testing Market The global Infectious Disease Diagnostic Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Infectious Disease Diagnostic Testing S…